Low dose steroid for new rheumatoid arthritis
Treatments studied
Part of Bones, joints & muscles, Immune system & allergy clinical trials.
This trial tests whether a very low dose of a steroid called prednisolone can help people recently diagnosed with rheumatoid arthritis manage their symptoms. It may reduce pain and swelling while limiting side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with rheumatoid arthritis based on current medical guidelines.
- You have never taken disease-modifying drugs (like methotrexate) for your rheumatoid arthritis.
- You are not pregnant or planning to become pregnant soon.
- You have not used steroid pills or injections in the last month.
- You do not have any medical condition that makes taking prednisolone unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two different ways of slowly lowering the dose of steroids (like prednisolone) in people with stable rheumatoid arthritis. The goal is to see which tapering schedule is safer and more effective, possibly reducing side effects while keeping the disease under control.
This study compares two different schedules for reducing prednisone (a steroid) in people with rheumatoid arthritis who are also taking another standard arthritis medicine. The goal is to find the safest and most effective way to taper off steroids without causing a flare-up.
This trial tests whether a plant-based diet can help people with rheumatoid arthritis who have mild disease activity. You must have had RA for at least a year, be on stable medication, and not smoke or take prednisolone.
This study looks at how well your adrenal glands work if you have rheumatoid arthritis and are taking a low dose of corticosteroids (steroids). It aims to see if these treatments affect your adrenal function and to identify what factors might be linked to any problems.
This trial tests whether spironolactone can reduce symptoms and inflammation in people with rheumatoid arthritis that is still active despite standard arthritis medicines. You may be able to join if your rheumatoid arthritis remains active and your current treatment plan has been stable for at least several months.
This study tests a new medication called AZD1163 for people with rheumatoid arthritis (RA) that hasn't responded well enough to standard treatments. It aims to see if the drug can safely reduce joint swelling and pain.
Hear when a new Rhematoid Arthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.